Rui Li , Sha He , Fengxia Wang , Shan Liu , Kunyao Xu , Meng Luo
{"title":"Morin induces autophagy-dependent ferroptosis in colorectal cancer cells by inhibiting the AURKB-UCHL3 interactions","authors":"Rui Li , Sha He , Fengxia Wang , Shan Liu , Kunyao Xu , Meng Luo","doi":"10.1016/j.cellsig.2025.111875","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Colorectal cancer (CRC) poses a significant threat to human health, and its underlying mechanisms require further exploration. Morin, a natural flavonoid, exhibits anti-CRC activity, but its molecular mechanisms remain unclear. This study aimed to evaluate its anti-CRC effects and elucidate its molecular mechanisms to provide new insights for CRC treatment.</div></div><div><h3>Methods</h3><div>Molecular docking predicted potential binding between morin and AURKB. Experimental validation included qPCR, Western blotting, co-immunoprecipitation, and immunofluorescence. Autophagy-dependent ferroptosis was assessed by measuring mitochondrial superoxide, MDA, GSH, and ROS levels, as well as NCOA4 and FTH1 expression.</div></div><div><h3>Results</h3><div>AURKB is highly expressed in CRC, and stabilized via interaction with the deubiquitinase UCHL3, which activated the PI3K/Akt/mTOR pathway and suppressed autophagy-dependent ferroptosis. This suppression was characterized by reduced mitochondrial superoxide, decreased MDA and ROS levels, elevated GSH, and upregulated FTH1. Morin disrupted the AURKB-UCHL3 interaction, promoted AURKB degradation, reversed ferroptosis inhibition, and suppressed CRC cell proliferation and migration.</div></div><div><h3>Conclusion</h3><div>This study is the first to demonstrate that morin inhibits CRC progression by targeting the AURKB-UCHL3 axis to regulate autophagy-dependent ferroptosis, providing experimental evidence for its therapeutic potential in CRC treatment.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"134 ","pages":"Article 111875"},"PeriodicalIF":4.4000,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular signalling","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0898656825002906","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Colorectal cancer (CRC) poses a significant threat to human health, and its underlying mechanisms require further exploration. Morin, a natural flavonoid, exhibits anti-CRC activity, but its molecular mechanisms remain unclear. This study aimed to evaluate its anti-CRC effects and elucidate its molecular mechanisms to provide new insights for CRC treatment.
Methods
Molecular docking predicted potential binding between morin and AURKB. Experimental validation included qPCR, Western blotting, co-immunoprecipitation, and immunofluorescence. Autophagy-dependent ferroptosis was assessed by measuring mitochondrial superoxide, MDA, GSH, and ROS levels, as well as NCOA4 and FTH1 expression.
Results
AURKB is highly expressed in CRC, and stabilized via interaction with the deubiquitinase UCHL3, which activated the PI3K/Akt/mTOR pathway and suppressed autophagy-dependent ferroptosis. This suppression was characterized by reduced mitochondrial superoxide, decreased MDA and ROS levels, elevated GSH, and upregulated FTH1. Morin disrupted the AURKB-UCHL3 interaction, promoted AURKB degradation, reversed ferroptosis inhibition, and suppressed CRC cell proliferation and migration.
Conclusion
This study is the first to demonstrate that morin inhibits CRC progression by targeting the AURKB-UCHL3 axis to regulate autophagy-dependent ferroptosis, providing experimental evidence for its therapeutic potential in CRC treatment.
期刊介绍:
Cellular Signalling publishes original research describing fundamental and clinical findings on the mechanisms, actions and structural components of cellular signalling systems in vitro and in vivo.
Cellular Signalling aims at full length research papers defining signalling systems ranging from microorganisms to cells, tissues and higher organisms.